KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Assets Average (2016 - 2025)

Historic Assets Average for Amgen (AMGN) over the last 16 years, with Q3 2025 value amounting to $89.0 billion.

  • Amgen's Assets Average fell 206.39% to $89.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $89.0 billion, marking a year-over-year decrease of 206.39%. This contributed to the annual value of $94.5 billion for FY2024, which is 1646.46% up from last year.
  • Amgen's Assets Average amounted to $89.0 billion in Q3 2025, which was down 206.39% from $88.6 billion recorded in Q2 2025.
  • Amgen's Assets Average's 5-year high stood at $95.1 billion during Q1 2024, with a 5-year trough of $59.2 billion in Q2 2022.
  • Moreover, its 5-year median value for Assets Average was $88.6 billion (2025), whereas its average is $78.0 billion.
  • Per our database at Business Quant, Amgen's Assets Average soared by 5105.83% in 2023 and then crashed by 469.56% in 2025.
  • Over the past 5 years, Amgen's Assets Average (Quarter) stood at $63.1 billion in 2021, then grew by 2.11% to $64.4 billion in 2022, then surged by 45.7% to $93.8 billion in 2023, then dropped by 2.65% to $91.4 billion in 2024, then dropped by 2.56% to $89.0 billion in 2025.
  • Its Assets Average was $89.0 billion in Q3 2025, compared to $88.6 billion in Q2 2025 and $90.6 billion in Q1 2025.